NCT07512271
Generative AI Patient Education Module for Breast Oncology
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 9 words
- Enrollment closed, study ongoing
- Secondary endpoints: details revised at 4 of 4 entries
- Site details revised
- Notable Recruitment opened
- Start date changed from estimate of Aug 15, 2026 to Jul 14, 2026
- Site details revised
- Notable Start date: May 1, 2026 to Aug 15, 2026
- Primary and study completion pushed from Dec 31, 2026 to Jan 31, 2027
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (4)
Arms and interventions
Participants will receive access to OpenEvidence CareConnect a Retrieval-Augmented Generation (RAG) Large Language Model (LLM) tool that provides general health and breast cancer-specific information for 3 months.
Participants will be given immediate access to OpenEvidence CareConnect for up to 3 months and complete surveys regarding use of tool. Participants are then followed up for an additional 3 months.
Participants will be given access to OpenEvidence CareConnect for 3 months 90 days after enrollment
Other: Survey (Participant), OpenEvidence CareConnect, Survey (Provider)
Sites
1 site in 1 country
- University of California, San FranciscoSan Francisco, California, United States